UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is there a future for EGFR targeted agents in esophageal cancer?

Annals of oncology, 2018-06, Vol.29 (6), p.1343-1344

Ilson, D.H.

2018

Volltextzugriff (PDF)

Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience

Annals of oncology, 2008-03, Vol.19 (3), p.533-537

2008

Volltextzugriff (PDF)

Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma

British journal of cancer, 2011-06, Vol.104 (12), p.1840-1847

2011

Volltextzugriff (PDF)

Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer

Annals of oncology, 2007-05, Vol.18 (5), p.898-902

2007

Volltextzugriff (PDF)

Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma

British journal of surgery, 2021-11, Vol.108 (11), p.1332

2021

Volltextzugriff (PDF)

Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway

Journal of virology, 2020-06, Vol.94 (13)

2020

Volltextzugriff (PDF)

Combined modality chemoradiation in elderly oesophageal cancer patients

British journal of cancer, 2007-06, Vol.96 (12), p.1823-1827

2007

Volltextzugriff (PDF)

Overall survival results from a phase III trial of trifluridine/tipiracil (FTD/TPI) vs placebo in patients (Pts) with metastatic gastric cancer refractory to standard therapies (TAGS)

Annals of oncology, 2018-11, Vol.29, p.ix55-ix55

2018

Volltextzugriff (PDF)

TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer

Annals of oncology, 2018-10, Vol.29, p.viii718-viii718

2018

Volltextzugriff (PDF)

Overall survival results from a phase III trial of trifluridine/tipiracil versus placebo in patients with metastatic gastric cancer refractory to standard therapies (TAGS)

Annals of oncology, 2018-06, Vol.29, p.v122-v122

2018

Volltextzugriff (PDF)

Phase III KEYNOTE-585 study of chemotherapy (Chemo) + pembrolizumab (Pembro) vs chemo + placebo as neoadjuvant/adjuvant treatment for patients (Pts) with gastric or gastroesophageal junction (G/GEJ) cancer

Annals of oncology, 2018-10, Vol.29, p.viii268-viii268

2018

Volltextzugriff (PDF)

Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer

ESMO open, 2022-12, Vol.7 (6), p.100633, Article 100633

2022

Volltextzugriff (PDF)

A phase 3 study of chemotherapy + pembrolizumab vs chemotherapy + placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer: KEYNOTE-585 - Trial in progress

Annals of oncology, 2018-06, Vol.29, p.v26-v26

2018

Volltextzugriff (PDF)

Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study

ESMO open, 2021-08, Vol.6 (4), p.100200, Article 100200

2021

Volltextzugriff (PDF)

The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona

Digestive and liver disease, 2016-11, Vol.48 (11), p.1283-1289

2016

Volltextzugriff (PDF)

Phase II Trial of Weekly Irinotecan Plus Cisplatin in Advanced Esophageal Cancer

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3270-3275

1999

Volltextzugriff (PDF)

Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy

Diseases of the esophagus, 2014-05, Vol.27 (4), p.355-359

2014

Volltextzugriff (PDF)

Phase II Study of the Cyclin-Dependent Kinase Inhibitor Flavopiridol Administered to Patients With Advanced Gastric Carcinoma

Journal of clinical oncology, 2001-04, Vol.19 (7), p.1985-1992

2001

Volltextzugriff (PDF)

Chemotherapy in esophageal cancer

Seminars in oncology, 1999-10, Vol.26 (5), p.12-20

1999

Volltextzugriff (PDF)

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus

Journal of clinical oncology, 1998-05, Vol.16 (5), p.1826-1834

1998

Volltextzugriff (PDF)

Prognostic Significance Of FDG-PET Metrics In Esophageal Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S12-S12

2014

Volltextzugriff (PDF)

Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma

JNCI : Journal of the National Cancer Institute, 2000-11, Vol.92 (22), p.1805-1811

2000

Volltextzugriff (PDF)

Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus

JNCI : Journal of the National Cancer Institute, 1994-07, Vol.86 (14), p.1086-1091

1994

Volltextzugriff (PDF)

Targeted Therapies for Esophageal Cancer

The oncologist (Dayton, Ohio), 2005-09, Vol.10 (8), p.590-601

2005

Volltextzugriff (PDF)

The Initial Report of Local Control on RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Treated Without Surgery

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S3-S3

2014

Volltextzugriff (PDF)

1 – 25 von 319

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(286)
Mit Volltextzugriff
(263)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(192)
Life Sciences & Biomedicine
(178)
Humans
(135)
Male
(82)
Oncology
(80)
Biological And Medical Sciences
(79)
Medical Sciences
(75)
Middle Aged
(69)
Adult
(66)
Female
(65)
Aged
(55)
Pharmacology. Drug Treatments
(53)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(41)
Animals
(39)
Chemotherapy
(36)
Esophageal Neoplasms - Drug Therapy
(36)
Combined Modality Therapy
(33)
Antineoplastic Agents
(30)
Otorhinolaryngology
(27)
Molecular Sequence Data
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Is there a future for EGFR targeted agents in esophageal cancer?

Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience

Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma

Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer

Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma

Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway

Combined modality chemoradiation in elderly oesophageal cancer patients

Overall survival results from a phase III trial of trifluridine/tipiracil (FTD/TPI) vs placebo in patients (Pts) with metastatic gastric cancer refractory to standard therapies (TAGS)

TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer

Overall survival results from a phase III trial of trifluridine/tipiracil versus placebo in patients with metastatic gastric cancer refractory to standard therapies (TAGS)

Phase III KEYNOTE-585 study of chemotherapy (Chemo) + pembrolizumab (Pembro) vs chemo + placebo as neoadjuvant/adjuvant treatment for patients (Pts) with gastric or gastroesophageal junction (G/GEJ) cancer

Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer

A phase 3 study of chemotherapy + pembrolizumab vs chemotherapy + placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer: KEYNOTE-585 - Trial in progress

Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study

The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona

Phase II Trial of Weekly Irinotecan Plus Cisplatin in Advanced Esophageal Cancer

Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy

Phase II Study of the Cyclin-Dependent Kinase Inhibitor Flavopiridol Administered to Patients With Advanced Gastric Carcinoma

Chemotherapy in esophageal cancer

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus

Prognostic Significance Of FDG-PET Metrics In Esophageal Squamous Cell Carcinoma

Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma

Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus

Targeted Therapies for Esophageal Cancer

The Initial Report of Local Control on RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Treated Without Surgery

Suchergebnisse filtern